Ashmore Emerging Markets Sm Cp Eq Instl ESCIX

Medalist Rating as of | See Ashmore Investment Hub
  • NAV / 1-Day Return 19.10  /  +0.58 %
  • Total Assets 10.7 Mil
  • Adj. Expense Ratio
    1.270%
  • Expense Ratio 1.270%
  • Distribution Fee Level High
  • Share Class Type Institutional
  • Category Diversified Emerging Mkts
  • Investment Style Mid Growth
  • Min. Initial Investment 1.0 Mil
  • Status Open
  • TTM Yield 0.51%
  • Turnover 79%

USD | NAV as of Sep 28, 2024 | 1-Day Return as of Sep 28, 2024, 12:17 AM GMT+0

Morningstar’s Analysis ESCIX

Will ESCIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Ashmore Emerging Markets Sm Cp Eq Instl earns a Morningstar Medalist Rating of Neutral with strength in areas such as Process offset by weaker spots such as People.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings ESCIX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 31.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

MY E.G.Services Bhd

5.43 575,180
Technology

WinWay Technology Co Ltd Ordinary Shares

3.95 418,904
Technology

E Ink Holdings Inc

3.68 389,920
Technology

Gudeng Precision Industrial Co Ltd

3.37 356,938
Technology

Dentium Co Ltd

3.09 327,998
Healthcare

Medi Assist Healthcare Services Ltd

2.67 283,520
Healthcare

Radico Khaitan Ltd

2.47 261,394
Consumer Defensive

Granules India Ltd

2.44 258,420
Healthcare

Eugene Technology Co Ltd

2.38 251,909
Technology

PB Fintech Ltd

2.29 242,643
Financial Services

Sponsor Center